pharmachologic effect

Zonisamide is an antiepileptic drug, a derivative of benzisoxazole, in vitro weakly inhibits carbonic anhydrase. Chemically, its structure is different from other antiepileptic drugs.

Indications

- monotherapy in adult patients with partial epileptic seizures with secondary generalization or without, with newly diagnosed epilepsy;

- as part of complementary therapy in adults, adolescents and children from age 6 with partial epileptic seizures with secondary generalization or without.